(:RAIN)
Business Focus: N/A
Jan 26, 2024 08:49 am ET
Pathos AI Completes Acquisition of Rain Oncology
Pathos AI, Inc. (“Pathos”) today announced that it has, through its wholly owned subsidiary WK Merger Sub, Inc. (“Merger Sub”), successfully completed its tender offer to acquire all outstanding shares of the common stock of Rain Oncology Inc. (Nasdaq: RAIN) (“Rain”) for $1.16 per share in cash plus one contingent value right per share (each, a “CVR”), which CVR shall represent the right to receive potential payments pursuant to the terms and subject to the conditions of the Contingent Value Rights Agreement, dated as of January 26, 2024, by and among Pathos, Merger Sub, Equiniti Trust Company
Jan 05, 2024 07:28 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FGH, RAIN, PGTI, AYX
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: FG Group Holdings Inc. (NYSE: FGH)’s...
Jan 04, 2024 09:08 pm ET
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Rain Oncology Inc. (NasdaqGS: RAIN) to Pathos AI, Inc. Under the terms of the proposed transaction, shareholders of Rain will receive $1.16 in cash plus a non-tradeable contingent value right for potential cash payments of up to approximately $0.17, for each share of Rain that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Jan 04, 2024 02:35 pm ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICVX, DSKE, RAIN, CNSL
NEW YORK, Jan. 4, 2024 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Jan 04, 2024 11:22 am ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc.
Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no...
Jan 03, 2024 01:57 pm ET
Kuehn Law Encourages EGLE, ICVX, RAIN, and AYX Investors to Contact Law Firm
NEW YORK, Jan. 3, 2024 /PRNewswire/ -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek additional disclosures or other relief on behalf of the shareholders of these companies.
Jan 01, 2024 09:23 am ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ICVX, CVLY, RAIN, X
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Icosavax, Inc. (NASDAQ: ICVX)’s sale...
Dec 27, 2023 08:29 pm ET
SHAREHOLDER ALERT: Juan Monteverde Encourages the Shareholders of SUM, X, PGTI, RAIN Take Action
NEW YORK, Dec. 27, 2023 /PRNewswire/ -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the "M&A Class Action Firm"), a national securities firm rated Top 50 in the 2018-2022 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is investigating:
Dec 27, 2023 02:34 pm ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RAIN, X, PGTI
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Rain Oncology Inc. (NASDAQ: RAIN)’s...
Dec 26, 2023 10:11 pm ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BVH, CERE, ICVX, RAIN
NEW YORK, Dec. 26, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Dec 26, 2023 02:27 pm ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Icosavax, Inc. (Nasdaq - ICVX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc.
Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no...
Dec 21, 2023 09:16 am ET
RAIN Alert: Monsey Firm of Wohl & Fruchter Investigating Fairness of the Sale of Rain Oncology to Pathos AI via a Tender Offer
The law firm of Wohl & Fruchter LLP is investigating the fairness of the $1.16 per share in cash, plus a contingent value right (“CVR”) for up to $0.17 per share in cash, at which Rain Oncology, Inc. (Nasdaq: RAIN) (“RAIN”) has agreed to be sold to...
Dec 18, 2023 05:25 pm ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CERE, EGLE, ICVX, RAIN
NEW YORK, Dec. 18, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:
Dec 18, 2023 02:21 pm ET
RAIN ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Rain Oncology Inc. - RAIN
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Rain Oncology Inc. (NasdaqGS: RAIN) to Pathos AI, Inc. Under the terms of the proposed transaction, shareholders of Rain will receive $1.16 in cash plus a non-tradeable contingent value right for potential cash payments of up to approximately $0.17, for each share of Rain that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.
Dec 18, 2023 12:36 pm ET
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Alteryx, Inc. (NYSE – AYX), Rain Oncology, Inc. (Nasdaq – RAIN), Consolidated Communications Holdings, Inc. (Na
Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky ([email protected]) or Marc Ackerman ([email protected]) at 855-576-4847. There is no...
Dec 16, 2023 12:25 pm ET
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RAIN, BLBX, AEZS
Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Rain Oncology Inc. (NASDAQ: RAIN)’s...
Dec 14, 2023 09:41 am ET
Shareholder Alert: Ademi LLP investigates whether Rain Oncology Inc. has obtained a Fair Price in its transaction with Pathos
MILWAUKEE, Dec. 14, 2023 /PRNewswire/ -- Ademi LLP is investigating Rain (NASDAQ: RAIN) for possible breaches of fiduciary duty and other violations of law in its transaction with Pathos.
Dec 14, 2023 02:42 am ET
RAIN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Rain Oncology Inc. Is Fair to Shareholders
Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Rain Oncology Inc. (NASDAQ: RAIN) to Pathos AI, Inc. for $1.16 in cash per share plus a non-tradeable contingent value right for potential cash payments of up to approximately $0.17 per share is fair to Rain shareholders.
Dec 13, 2023 06:05 pm ET
Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights
Rain Oncology Inc. (Nasdaq: RAIN) (“Rain”), today announced it has entered into a definitive merger agreement whereby Pathos AI, Inc. (“Pathos”) will acquire Rain for $1.16 in cash per share plus a non-tradeable contingent value right (a “CVR”) for...
Nov 09, 2023 04:01 pm ET
Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
Rain Oncology Inc. (NasdaqGS: RAIN) (Rain) today reported financial results for the third quarter ended September 30, 2023, along with an update on the Company’s key developments and business operations. “Rain continues to evaluate a number of...
Oct 16, 2023 08:00 am ET
Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
Rain Oncology, Inc. (NasdaqGS: RAIN) (“Rain”) confirmed that it has received an unsolicited proposal from Tang Capital, LP on behalf of Concentra Biosciences LLC to acquire all outstanding shares of common stock of Rain for $1.25 per share in cash,...
Sep 12, 2023 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)
NEW YORK, Sept. 12, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc..
Sep 11, 2023 10:15 pm ET
ROSEN, A TOP RANKED LAW FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - RAIN
NEW YORK, Sept. 11, 2023 /PRNewswire/ --
Sep 11, 2023 06:00 pm ET
SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit
NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Sep 11, 2023 05:37 pm ET
Rain Oncology Inc: Please contact the Portnoy Law Firm to recover your losses; September 12, 2023 deadline.
The Portnoy Law Firm advises Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN) investors that a lawsuit filed on behalf of investors that purchased Rain securities between July 20, 2021 and May 19, 2023, both dates inclusive (the “Class...
Sep 11, 2023 12:30 pm ET
SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop – Levi & Korsinsky Pursuing Class Action Lawsuit
NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Sep 11, 2023 12:10 pm ET
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. (RAIN) Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rain investors who were adversely...
Sep 11, 2023 12:00 pm ET
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)
The Law Offices of Frank R. Cruz reminds investors of the upcoming September 12, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ:
Sep 11, 2023 11:45 am ET
SHAREHOLDER ALERT: Potential Recovery for Rain Oncology Inc. (RAIN) Investors Affected by Stock Drop - Levi & Korsinsky Pursuing Class Action Lawsuit
NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:
Sep 11, 2023 11:05 am ET
DEADLINE ALERT for BAX, RAIN, PTRA, and SE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Sep 11, 2023 05:45 am ET
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Rain Investors of a Lead Plaintiff Deadline of September 12, 2023
NEW YORK, Sept. 11, 2023 /PRNewswire/ -- Attention Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) shareholders:
Sep 09, 2023 12:36 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rain Oncology Inc. - RAIN
Pomerantz LLP is investigating claims on behalf of investors of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Sep 08, 2023 09:00 pm ET
RAIN DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Rain Oncology, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Rain Oncology, Inc. (“Rain” or the “Company”) (NASDAQ: RAIN) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Rain securities between July 20, 2021, and May 19, 2023, both dates inclusive (the “Class Period”). Investors have until September 12, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Sep 08, 2023 06:16 pm ET
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action – RAIN
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19, 2023, both dates inclusive (the “Class Period”), of the important September 12, 2023...
Sep 08, 2023 12:23 pm ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 – (NASDAQ: RAIN)
The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc. Shareholders who purchased shares of RAIN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment....
Sep 06, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Baxter, Rain, and Danaher, and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Baxter International, Inc. (NYSE: BAX), Rain Oncology, Inc. (NASDAQ: RAIN), and...
Sep 06, 2023 02:58 pm ET
DEADLINE ALERT for PTRAQ, RAIN, SE, BHC: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Sep 06, 2023 12:48 pm ET
SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc.(RAIN) Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Company violated federal securities laws. Class Period: July 20, 2021 to May 19, 2023Lead...
Sep 05, 2023 12:25 pm ET
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. (RAIN) Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rain investors who were adversely...
Sep 05, 2023 12:06 pm ET
DEADLINE ALERT for BAX, RAIN, PTRA, and SE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Sep 02, 2023 07:00 pm ET
Lifshitz Law PLLC Announces Investigations of Rain Oncology, Inc. (NASDAQ: RAIN), Danaher Corp. (NYSE: DHR), Bausch Health Companies, Inc. (NYSE: BHC), and AT&T Inc. (NYSE: T)
Rain Oncology, Inc. (NASDAQ: RAIN) Lifshitz Law PLLC announces investigation into possible securities laws violations and/or breaches of fiduciary duties in connection with allegations that the Company made false and/or misleading statements...
Sep 01, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Seagate, Baxter, and Rain and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Seagate Technology Holdings Plc (NASDAQ: STX), Baxter International, Inc. (NYSE:...
Sep 01, 2023 12:18 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rain Oncology Inc. - RAIN
Pomerantz LLP is investigating claims on behalf of investors of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Aug 31, 2023 12:45 pm ET
SHAREHOLDER ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc. (RAIN) Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Company violated federal securities laws. Class Period: July 20, 2021 to May 19, 2023Lead...
Aug 31, 2023 12:37 pm ET
RAIN Investors: Contact Robbins LLP for Information Regarding the Pending Lead Plaintiff Deadline in the Rain Oncology Inc. Securities Fraud Class Action
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Rain Oncology Inc. (NASDAQ: RAIN) securities between July 20, 2021 and May 19, 2023. Rain Oncology is a...
Aug 31, 2023 10:45 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 12, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Rain Oncology Inc. (“Rain” or the...
Aug 30, 2023 01:06 pm ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 – (NASDAQ: RAIN)
The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc.. Shareholders who purchased shares of RAIN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment....
Aug 29, 2023 09:03 am ET
DEADLINE ALERT for PTRAQ, RAIN, SE, BHC: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Aug 28, 2023 01:11 pm ET
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Rain Oncology Inc.(RAIN) Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rain investors who were adversely...
Aug 28, 2023 12:36 pm ET
DEADLINE ALERT for BAX, RAIN, PTRA, and SE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Aug 27, 2023 09:00 pm ET
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Rain, Proterra, and Danaher and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Rain Oncology, Inc. (NASDAQ: RAIN), Proterra, Inc. (NASDAQ: PTRA), and Danaher...
Aug 26, 2023 12:44 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rain Oncology Inc. - RAIN
Pomerantz LLP is investigating claims on behalf of investors of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Aug 25, 2023 05:24 pm ET
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RAIN
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19, 2023, both dates inclusive (the “Class Period”), of the important September 12, 2023...
Aug 25, 2023 12:26 pm ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 – (NASDAQ: RAIN)
The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc. Shareholders who purchased shares of RAIN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment....
Aug 25, 2023 09:30 am ET
Calling All Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit!
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rain Oncology Inc. ("Rain" or “the Company”) (NASDAQ: RAIN) and certain of its...
Aug 24, 2023 12:49 pm ET
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. (RAIN) Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rain investors who were adversely...
Aug 24, 2023 11:34 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 12, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Rain Oncology Inc. (“Rain” or the...
Aug 22, 2023 09:00 pm ET
RAIN ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Rain Oncology, Inc. and Encourages Investors to Contact the Firm
Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against Rain Oncology, Inc. (“Rain” or the “Company”) (NASDAQ: RAIN) in the United States District Court for the Northern District of California on behalf of all persons and entities who purchased or otherwise acquired Rain securities between July 20, 2021, and May 19, 2023, both dates inclusive (the “Class Period”). Investors have until September 12, 2023 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
Aug 22, 2023 12:45 pm ET
DEADLINE ALERT for PTRA, RAIN, SE, BHC: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Aug 22, 2023 12:28 pm ET
RAIN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc. Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Company violated federal securities laws. Class Period: July 20, 2021 to May 19, 2023Lead...
Aug 22, 2023 11:13 am ET
DEADLINE ALERT for BAX, RAIN, PTRA, and SE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Aug 21, 2023 01:08 pm ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 – (NASDAQ: RAIN)
The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc. Shareholders who purchased shares of RAIN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment....
Aug 19, 2023 05:52 pm ET
ROSEN, TRUSTED INVESTOR COUNSEL, FIRM Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RAIN
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19, 2023, both dates inclusive (the “Class Period”), of the important September 12, 2023...
Aug 18, 2023 12:42 pm ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 12, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Rain Oncology Inc. (“Rain” or the...
Aug 18, 2023 12:23 pm ET
RAIN LAWSUIT ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rain investors who were adversely...
Aug 18, 2023 09:30 am ET
Calling All Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit!
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rain Oncology Inc. ("Rain" or “the Company”) (NASDAQ: RAIN) and certain of its...
Aug 18, 2023 06:30 am ET
RAIN LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Rain Oncology Inc.
NEW YORK, NY / ACCESSWIRE / August 18, 2023 / The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Rain Oncology Inc. ("Rain") (NASDAQ:RAIN) between July 20, 2021 and May 19, 2023.
Aug 16, 2023 04:15 pm ET
RAIN LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving Rain Oncology Inc.
NEW YORK, NY / ACCESSWIRE / August 16, 2023 / The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased Rain Oncology Inc. ("Rain") (NASDAQ:RAIN) between July 20, 2021 and May 19, 2023.
Aug 16, 2023 11:51 am ET
RAIN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc. Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Company violated federal securities laws. Class Period: July 20, 2021 to May 19, 2023Lead...
Aug 15, 2023 09:35 pm ET
DEADLINE ALERT for PTRA, RAIN, SE, BHC: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Aug 15, 2023 11:56 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Rain Investors of a Lead Plaintiff Deadline of September 12, 2023
Attention Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between July 20, 2021 and May 19, 2023. If you suffered a...
Aug 15, 2023 11:15 am ET
DEADLINE ALERT for BAX, RAIN, PTRA, and SE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Aug 14, 2023 12:52 pm ET
RAIN LAWSUIT ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rain investors who were adversely...
Aug 14, 2023 11:53 am ET
RAIN, PTRA, BTAI, Class Action Update: Johnson Fistel Alerts Shareholders of Ongoing Legal Proceedings
Johnson Fistel, LLP, a law firm specializing in shareholder rights, has announced the initiation of class action lawsuits on behalf of investors of the following companies. Investors are encouraged to review the deadlines listed and submit their...
Aug 13, 2023 10:03 am ET
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – RAIN
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19, 2023, both dates inclusive (the “Class Period”), of the important September 12, 2023...
Aug 12, 2023 01:41 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rain Oncology Inc. - RAIN
Pomerantz LLP is investigating claims on behalf of investors of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Aug 11, 2023 12:35 pm ET
RAIN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc. Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Company violated federal securities laws. Class Period: July 20, 2021 to May 19, 2023Lead...
Aug 11, 2023 09:30 am ET
Calling All Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit!
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rain Oncology Inc. ("Rain" or “the Company”) (NASDAQ: RAIN) and certain of its...
Aug 10, 2023 04:05 pm ET
Rain Oncology Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Rain Oncology Inc. (NasdaqGS: RAIN), (Rain), today reports financial results for the second quarter ended June 30, 2023, and provides a corporate update. “Rain has been aggressively pursuing a multitude of opportunities as we seek to leverage our...
Aug 10, 2023 11:43 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 – (NASDAQ: RAIN)
The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc. Shareholders who purchased shares of RAIN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment....
Aug 10, 2023 11:17 am ET
DEADLINE ALERT for BAX, RAIN, PTRA, and SE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Aug 10, 2023 10:30 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 12, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Rain Oncology Inc. (“Rain” or the...
Aug 09, 2023 01:21 pm ET
RAIN SHAREHOLDER ALERT: Jakubowitz Law Reminds Rain Shareholders of a Lead Plaintiff Deadline of September 12, 2023
Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN). To receive updates on the lawsuit, fill out the...
Aug 08, 2023 06:06 pm ET
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RAIN
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19, 2023, both dates inclusive (the “Class Period”), of the important September 12, 2023...
Aug 08, 2023 03:42 pm ET
DEADLINE ALERT for PTRA, RAIN, SE, BHC: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders
Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Aug 08, 2023 01:09 pm ET
RAIN LAWSUIT ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rain investors who were adversely...
Aug 08, 2023 06:00 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Rain Oncology Inc. with Losses of $750,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / August 8, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Aug 07, 2023 12:42 pm ET
RAIN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc. Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Company violated federal securities laws. Class Period: July 20, 2021 to May 19, 2023Lead...
Aug 04, 2023 12:41 pm ET
RAIN LAWSUIT ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rain investors who were adversely...
Aug 04, 2023 10:08 am ET
RAIN, PTRA, BTAI, Class Action Update: Johnson Fistel Alerts Shareholders of Ongoing Legal Proceedings
Johnson Fistel, LLP, a law firm specializing in shareholder rights, has announced the initiation of class action lawsuits on behalf of investors of the following companies. Investors are encouraged to review the deadlines listed and submit their...
Aug 04, 2023 09:30 am ET
Calling All Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit!
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rain Oncology Inc. ("Rain" or “the Company”) (NASDAQ: RAIN) and certain of its...
Aug 03, 2023 03:26 pm ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 – (NASDAQ: RAIN)
The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc. Shareholders who purchased shares of RAIN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment....
Aug 03, 2023 01:12 pm ET
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Rain Oncology Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – RAIN
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19, 2023, both dates inclusive (the “Class Period”), of the important September 12, 2023...
Aug 03, 2023 11:40 am ET
DEADLINE ALERT for BAX, RAIN, PTRA, and SE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Aug 02, 2023 05:01 pm ET
Rain Oncology Inc. (RAIN) Shareholders: Contact Robbins LLP for Information Regarding the Rain Oncology Inc. Securities Fraud Class Action
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Rain Oncology Inc. (NASDAQ: RAIN) securities between July 20, 2021 and May 19, 2023. Rain Oncology is a...
Aug 02, 2023 04:03 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rain Oncology Inc. - RAIN
Pomerantz LLP is investigating claims on behalf of investors of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Aug 02, 2023 12:28 pm ET
RAIN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc. Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Company violated federal securities laws. Class Period: July 20, 2021 to May 19, 2023Lead...
Aug 02, 2023 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)
NEW YORK, Aug. 2, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc..
Aug 01, 2023 12:46 pm ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Rain Investors of a Lead Plaintiff Deadline of September 12, 2023
Attention Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between July 20, 2021 and May 19, 2023. If you suffered a...
Aug 01, 2023 11:04 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 12, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Rain Oncology Inc. (“Rain” or the...
Aug 01, 2023 05:45 am ET
RAIN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc. Shareholders
NEW YORK, Aug. 1, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Company violated federal securities laws.
Jul 31, 2023 12:55 pm ET
RAIN LAWSUIT ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rain investors who were adversely...
Jul 31, 2023 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Rain Investors of a Lead Plaintiff Deadline of September 12, 2023
NEW YORK, July 31, 2023 /PRNewswire/ -- Attention Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) shareholders:
Jul 28, 2023 02:15 pm ET
RAIN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc. Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Company violated federal securities laws. Class Period: July 20, 2021 to May 19, 2023Lead...
Jul 28, 2023 01:50 pm ET
Jul 28, 2023 09:30 am ET
Calling All Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit!
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rain Oncology Inc. ("Rain" or “the Company”) (NASDAQ: RAIN) and certain of its...
Jul 28, 2023 05:45 am ET
RAIN SHAREHOLDER ALERT: Jakubowitz Law Reminds Rain Shareholders of a Lead Plaintiff Deadline of September 12, 2023
NEW YORK, July 28, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN).
Jul 27, 2023 03:20 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rain Oncology Inc. - RAIN
Pomerantz LLP is investigating claims on behalf of investors of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Jul 27, 2023 03:05 pm ET
Rain Oncology Inc. Class Action: RAIN Investors Should Contact Robbins LLP if They Suffered Financial Losses in Excess of $100,000
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Rain Oncology Inc. (NASDAQ: RAIN) securities between July 20, 2021 and May 19, 2023. Rain Oncology is a...
Jul 27, 2023 01:53 pm ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 – (NASDAQ: RAIN)
The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc. Shareholders who purchased shares of RAIN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment....
Jul 27, 2023 11:45 am ET
Jul 27, 2023 11:27 am ET
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Rain Oncology Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – RAIN
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19, 2023, both dates inclusive (the...
Jul 27, 2023 10:30 am ET
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)
Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming September 12, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ:
Jul 27, 2023 05:45 am ET
RAIN LAWSUIT ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, July 27, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit.
Jul 26, 2023 12:41 pm ET
RAIN SHAREHOLDER ALERT: Jakubowitz Law Reminds Rain Shareholders of a Lead Plaintiff Deadline of September 12, 2023
Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN). To receive updates on the lawsuit, fill out the...
Jul 26, 2023 11:08 am ET
DEADLINE ALERT for BAX, RAIN, and PTRA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jul 26, 2023 08:00 am ET
Rain Oncology to Report Second Quarter 2023 Financial Results and Provide a Corporate Update on August 10, 2023
Rain Oncology Inc. (NasdaqGS: RAIN), (“Rain”) today announced it will report financial results for the second quarter ended June 30, 2023 and provide a corporate update on Thursday, August 10, 2023. On that day, management will host a conference...
Jul 26, 2023 06:00 am ET
INVESTOR DEADLINE ALERT: The Schall Law Firm Encourages Investors in Rain Oncology Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / July 26, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jul 26, 2023 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)
NEW YORK, July 26, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc..
Jul 25, 2023 05:27 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rain Oncology Inc. - RAIN
NEW YORK, July 25, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
Jul 25, 2023 02:56 pm ET
RAIN LAWSUIT ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rain investors who were adversely...
Jul 25, 2023 01:15 pm ET
RAIN EQUITY ALERT: ROSEN, A LEADING NATIONAL FIRM, Encourages Rain Oncology Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – RAIN
WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 19, 2023, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than September 12, 2023.
Jul 25, 2023 09:37 am ET
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Rain Oncology Inc. (RAIN)
Law Offices of Howard G. Smith reminds investors of the upcoming September 12, 2023 deadline to file a lead plaintiff motion in the case filed on behalf of investors who purchased Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN) securities between July 20, 2021 and May 19, 2023, inclusive (the “Class Period”).
Jul 25, 2023 05:45 am ET
RAIN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc. Shareholders
NEW YORK, July 25, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Company violated federal securities laws.
Jul 24, 2023 05:32 pm ET
Rain Oncology Inc: Please contact the Portnoy Law Firm to recover your losses; September 12, 2023 deadline
The Portnoy Law Firm advises Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN) investors that a lawsuit filed on behalf of investors that purchased Rain securities between July 20, 2021 and May 19, 2023, both dates inclusive (the “Class...
Jul 24, 2023 03:27 pm ET
Rain Oncology Inc. (RAIN) Class Action Alert: Robbins LLP Reminds Investors of Lead Plaintiff Deadline in Rain Oncology Inc. Securities Class Action
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Rain Oncology Inc. (NASDAQ: RAIN) securities between July 20, 2021 and May 19, 2023. Rain Oncology is a late-stage precision oncology company that develops therapies that target oncogenic drive
Jul 24, 2023 12:42 pm ET
RAIN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc. Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Company violated federal securities laws. Class Period: July 20, 2021 to May 19, 2023Lead...
Jul 24, 2023 12:15 pm ET
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Rain Oncology Inc. (RAIN) Investors
The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of persons and entities that purchased or otherwise acquired Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ:
Jul 24, 2023 12:05 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Rain Oncology Inc. (RAIN) Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purchased or otherwise acquired Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ:
Jul 24, 2023 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Rain Investors of a Lead Plaintiff Deadline of September 12, 2023
NEW YORK, July 24, 2023 /PRNewswire/ -- Attention Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) shareholders:
Jul 24, 2023 03:00 am ET
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Rain Oncology Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / July 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jul 21, 2023 12:51 pm ET
RAIN LAWSUIT ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Rain investors who were adversely...
Jul 21, 2023 12:41 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Rain Oncology Inc. (RAIN) Investors
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN) securities between July 20, 2021 and May 19, 2023, inclusive (the “Class Period”). Rain investors have until September 12, 2023 to file a lead plaintiff mo
Jul 21, 2023 11:16 am ET
DEADLINE ALERT for BAX, RAIN, and PTRA: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders
The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion....
Jul 21, 2023 09:37 am ET
Calling All Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit!
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rain Oncology Inc. ("Rain" or “the Company”) (NASDAQ: RAIN) and certain of its...
Jul 21, 2023 06:00 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Rain Oncology Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / July 21, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jul 21, 2023 05:45 am ET
RAIN SHAREHOLDER ALERT: Jakubowitz Law Reminds Rain Shareholders of a Lead Plaintiff Deadline of September 12, 2023
NEW YORK, July 21, 2023 /PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN).
Jul 20, 2023 03:02 pm ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 – (NASDAQ: RAIN)
The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc. Shareholders who purchased shares of RAIN during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment....
Jul 20, 2023 07:00 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Rain Oncology Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / July 20, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jul 20, 2023 05:45 am ET
RAIN LAWSUIT ALERT: Levi & Korsinsky Notifies Rain Oncology Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
NEW YORK, July 20, 2023 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) of a class action securities lawsuit.
Jul 19, 2023 06:17 pm ET
Rain Oncology Inc. (RAIN) Shareholder Notice: Robbins LLP Reminds Investors of Class Action Against Rain Oncology Inc.
Robbins LLP reminds investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Rain Oncology Inc. (NASDAQ: RAIN) securities between July 20, 2021 and May 19, 2023. Rain Oncology is a...
Jul 19, 2023 04:11 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rain Oncology Inc. - RAIN
Pomerantz LLP is investigating claims on behalf of investors of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Jul 19, 2023 04:00 pm ET
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Rain Oncology Inc. (RAIN) on Behalf of Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ:
Jul 19, 2023 02:28 pm ET
Calling All Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit!
Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rain Oncology Inc. ("Rain" or “the Company”) (NASDAQ: RAIN) and certain of its officers.
Jul 19, 2023 02:24 pm ET
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Rain Oncology Inc. (RAIN) on Behalf of Investors
Law Offices of Howard G. Smith announces an investigation on behalf of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN) investors concerning the Company’s possible violations of federal securities laws.
Jul 19, 2023 07:00 am ET
SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in Rain Oncology Inc. with Losses of $100,000 to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rain Oncology Inc. (“Rain” or “the Company”) (NASDAQ:
Jul 19, 2023 06:00 am ET
INVESTOR DEADLINE ALERT: The Schall Law Firm Encourages Investors in Rain Oncology Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / July 19, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jul 19, 2023 05:45 am ET
RAIN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc. Shareholders
The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Company violated federal securities laws. Class Period: July 20, 2021 to May 19, 2023Lead...
Jul 19, 2023 05:45 am ET
SHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of September 12, 2023 - (NASDAQ: RAIN)
NEW YORK, July 19, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc..
Jul 18, 2023 07:55 pm ET
The Law Offices of Frank R. Cruz Announces Investigation of Rain Oncology Inc. (RAIN) on Behalf of Investors
The Law Offices of Frank R. Cruz announces an investigation of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ:
Jul 18, 2023 01:27 pm ET
Calling All Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit!
Attorney Advertising-- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rain Oncology Inc. ("Rain" or “the Company”) (NASDAQ: RAIN) and certain of its officers.
Jul 18, 2023 06:00 am ET
DEADLINE ACTION NOTICE: The Schall Law Firm Encourages Investors in Rain Oncology Inc. with Losses of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / July 18, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Jul 18, 2023 05:45 am ET
CLASS ACTION ALERT: The Law Offices of Vincent Wong Remind Rain Investors of a Lead Plaintiff Deadline of September 12, 2023
Attention Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behalf of investors who purchased between July 20, 2021 and May 19, 2023. If you suffered a...
Jul 18, 2023 05:45 am ET
RAIN ALERT: The Klein Law Firm Announces a Lead Plaintiff Deadline of September 12, 2023 in the Class Action Filed on Behalf of Rain Oncology Inc. Shareholders
NEW YORK, July 18, 2023 /PRNewswire/ -- The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN) alleging that the Company violated federal securities laws.
Jul 17, 2023 06:12 pm ET
Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Rain Oncology Inc. (RAIN)
Gainey McKenna & Egleston announces that a securities class action lawsuit has been filed in the United States District Court for the Northern District of California on behalf of all persons or entities who purchased the securities of Rain Oncology...
Jul 17, 2023 03:30 pm ET
Calling All Rain Oncology Inc. (RAIN) Investors: Contact Bronstein, Gewirtz & Grossman, LLC to Actively Participate in the Class Action Lawsuit!
NEW YORK, July 17, 2023 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ: RAIN) and certain of its officers.
Jul 17, 2023 01:21 pm ET
Shareholder Alert: Robbins LLP Informs Investors of Class Action Against Rain Oncology Inc. (RAIN)
Robbins LLP informs investors that a shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired Rain Oncology Inc. (NASDAQ: RAIN) securities between July 20, 2021 and May 19, 2023. Rain Oncology is a late-stage precision oncology company that develops therapies that target oncogenic drive
Jul 17, 2023 06:00 am ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / July 17, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of the securities laws.
Jul 14, 2023 06:05 pm ET
INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of Rain Oncology Inc. Securities and Sets a Lead Plaintiff Deadline of Septem
The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN) between July 20, 2021 to May 19, 2023,...
Jul 08, 2023 07:00 am ET
INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / July 8, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ: RAIN) for violations of the securities laws.
Jul 07, 2023 06:00 am ET
INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses In Excess of $100,000 to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / July 7, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of the securities laws.
Jul 06, 2023 05:45 am ET
INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of an Investigation and Potential Class Action Lawsuit - (NASDAQ: RAIN)
NEW YORK, July 6, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc.:
Jul 03, 2023 11:55 pm ET
Jul 03, 2023 05:45 am ET
RAIN ALERT: The Law Offices of Vincent Wong Investigate Rain Oncology Inc. for Potential Violations of Securities Laws
NEW YORK, July 3, 2023 /PRNewswire/ -- Attention Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) shareholders:
Jun 30, 2023 01:15 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 30, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of the securities laws.
Jun 30, 2023 05:45 am ET
RAIN FRAUD ALERT: Jakubowitz Law is Investigating Rain Oncology Inc. in Connection with Potential Violations of Federal Securities Laws
NEW YORK, June 30, 2023 /PRNewswire/ -- Jakubowitz Law announces that an investigation into potential securities fraud allegations has commenced on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN)
Jun 29, 2023 05:45 am ET
RAIN INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Rain Oncology Inc.
NEW YORK, June 29, 2023 /PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) concerning possible violations of federal securities laws.
Jun 28, 2023 05:45 am ET
INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of an Investigation and Potential Class Action Lawsuit - (NASDAQ: RAIN)
NEW YORK, June 28, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc.:
Jun 27, 2023 05:45 am ET
RAIN NEWS: The Klein Law Firm Initiates an Investigation Involving Possible Securities Fraud Violations by Officers of Rain Oncology Inc.
NEW YORK, June 27, 2023 /PRNewswire/ -- The Klein Law Firm announces that it is investigating allegations that Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) violated federal securities laws.
Jun 26, 2023 05:45 am ET
RAIN ALERT: The Law Offices of Vincent Wong Investigate Rain Oncology Inc. for Potential Violations of Securities Laws
NEW YORK, June 26, 2023 /PRNewswire/ -- Attention Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) shareholders:
Jun 23, 2023 05:45 am ET
RAIN FRAUD ALERT: Jakubowitz Law is Investigating Rain Oncology Inc. in Connection with Potential Violations of Federal Securities Laws
NEW YORK, June 23, 2023 /PRNewswire/ -- Jakubowitz Law announces that an investigation into potential securities fraud allegations has commenced on behalf of shareholders of Rain Oncology Inc. (NASDAQ: RAIN)
Jun 22, 2023 06:00 am ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSIWRE / June 22, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of the securities laws.
Jun 22, 2023 05:45 am ET
RAIN INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Rain Oncology Inc.
NEW YORK, June 22, 2023 /PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) concerning possible violations of federal securities laws.
Jun 21, 2023 06:00 am ET
INVESTIGATION ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 21, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of the securities laws.
Jun 21, 2023 05:45 am ET
INVESTIGATION ALERT: The Gross Law Firm Notifies Shareholders of Rain Oncology Inc. of an Investigation and Potential Class Action Lawsuit - (NASDAQ: RAIN)
NEW YORK, June 21, 2023 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Rain Oncology Inc.:
Jun 20, 2023 05:12 am ET
RAIN INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Rain Oncology Inc.
Levi & Korsinsky notifies investors that it has commenced an investigation of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN) concerning possible violations of federal securities laws. On or around April 22, 2021, Rain conducted its...
Jun 19, 2023 07:54 pm ET
RAIN INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by Officers of Rain Oncology Inc.
NEW YORK, June 19, 2023 /PRNewswire/ -- Levi & Korsinsky notifies investors that it has commenced an investigation of Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN) concerning possible violations of federal securities laws.
Jun 17, 2023 10:17 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rain Oncology Inc. - RAIN
Pomerantz LLP is investigating claims on behalf of investors of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
Jun 01, 2023 02:40 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / June 1, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of the securities laws.
May 31, 2023 11:45 am ET
INVESTOR ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 31, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of the securities laws.
May 30, 2023 04:35 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rain Oncology Inc. - RAIN
NEW YORK, May 30, 2023 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Rain Oncology Inc. ("Rain" or the "Company") (NASDAQ: RAIN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980.
May 30, 2023 08:30 am ET
Rain Oncology Provides Company Update and Outlines Strategic Priorities of Milademetan Clinical Programs
Rain Oncology Inc. (NasdaqGS: RAIN), (Rain), a clinical stage company developing precision oncology therapeutics today announced an update to its clinical strategy for milademetan, its small molecule inhibitor of the MDM2-p53 complex, to optimize...
May 28, 2023 07:40 pm ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 28, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ: RAIN) for violations of the securities laws.
May 27, 2023 11:34 pm ET
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rain Oncology Inc. - RAIN
Pomerantz LLP is investigating claims on behalf of investors of Rain Oncology Inc. (“Rain” or the “Company”) (NASDAQ: RAIN). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 7980. The...
May 26, 2023 09:50 pm ET
ONGOING INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 26, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of the securities laws.
May 25, 2023 11:00 pm ET
INVESTOR ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 25, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of the securities laws.
May 25, 2023 10:30 am ET
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rain Oncology Inc. (“Rain” or “the Company”) (NASDAQ:
May 24, 2023 10:00 pm ET
SHAREHOLDER ACTION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 24, 2023 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rain Oncology Inc. ("Rain" or "the Company") (NASDAQ:RAIN) for violations of the securities laws.
May 24, 2023 05:28 pm ET
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Rain Oncology Inc. and Encourages Investors with Losses to Contact the Firm
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Rain Oncology Inc. (“Rain” or “the Company”) (NASDAQ:
May 22, 2023 11:40 am ET
Thinking about buying stock in Palantir Technologies, DraftKings, Micron Technology, Rain Oncology, or VectivBio?
NEW YORK, May 22, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for PLTR, DKNG, MU, RAIN, and VECT.
May 22, 2023 08:00 am ET
Rain Oncology Announces Topline Results from Phase 3 MANTRA Trial of Milademetan for the Treatment of Dedifferentiated Liposarcoma
Rain Oncology Inc. (NasdaqGS: RAIN), (Rain), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule inhibitor of the MDM2-p53 complex that reactivates p53, today...
May 11, 2023 04:05 pm ET
Rain Oncology Reports First Quarter 2023 Financial Results and Highlights Recent Progress
Rain Oncology Inc. (NasdaqGS: RAIN), (Rain), a late-stage biotechnology company developing precision oncology therapeutics with a lead candidate, milademetan, an oral, small molecule inhibitor of the MDM2-p53 complex that reactivates p53, today...
Apr 24, 2023 08:00 am ET
Rain Oncology to Report First Quarter 2023 Financial Results and Highlights Recent Progress on May 11, 2023
Rain Oncology Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage biotechnology company developing precision oncology therapeutics with a lead product candidate, milademetan, an oral, small molecule inhibitor of the MDM2-p53 complex that reactivates p53,...
Apr 05, 2023 08:00 am ET
Rain Oncology Announces Collaborator Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2023
Rain Oncology Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule inhibitor of the MDM2-p53 complex that reactivates p53, today...
Mar 21, 2023 05:50 am ET
Rain Oncology Announces Oral Presentation at the 2023 ESMO Sarcoma and Rare Cancers Annual Congress
Rain Oncology Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule inhibitor of the MDM2-p53 complex that reactivates p53, today...
Mar 09, 2023 04:05 pm ET
Rain Oncology Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Recent Progress
Rain Oncology Inc. (NasdaqGS: RAIN), (Rain), a late-stage biotechnology company developing precision oncology therapeutics with its product candidate, milademetan, an oral, small molecule inhibitor of the MDM2-p53 complex that reactivates p53,...
Mar 07, 2023 08:00 am ET
Rain Oncology to Present At Oppenheimer 33rd Annual Healthcare Conference
Rain Oncology Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule inhibitor of the MDM2-p53 complex that reactivates p53, today...
Feb 23, 2023 08:00 am ET
Rain Oncology to Report Fourth Quarter and Full Year 2022 Financial Results and Highlights of Recent Progress on March 9, 2023
Rain Oncology Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage biotechnology company developing precision oncology therapeutics with a lead product candidate, milademetan, an oral, small molecule inhibitor of the MDM2-p53 complex that reactivates p53,...
Feb 09, 2023 08:00 am ET
Rain Oncology to Participate in the 2023 Citi Virtual Oncology Leadership Summit
Rain Oncology Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage company developing precision oncology therapeutics with its lead product candidate, milademetan, an oral, small molecule inhibitor of the p53-MDM2 complex that reactivates p53, today...
Jan 31, 2023 04:27 pm ET
UPDATE – Rain Oncology to Participate in the 2023 Guggenheim Healthcare Talks Oncology Day Conference
In a release issued earlier today by Rain Oncology (NASDAQ: RAIN), the company is updating their presentation date and time to Thursday, February 9, 2023, at 3:55 p.m. ET. Rain Oncology Inc. (NasdaqGS: RAIN), (“Rain”), a late-stage company...
Disclaimer :: Use of this site is subject to, and your continued use
constitutes your express agreement to be bound by, our Legal and Terms of Use. Any commercial use of this site is
strictly prohibited. Insidertracking.com is operated by INK Research Corp (INK). INK provides general information.
INK has made all reasonable efforts to ensure that all information provided is accurate at the time of inclusion;
however, there may be errors. INK makes no guarantee of accuracy or completeness. All information and opinion
expressed herein is subject to change without notice. Insider information is based on filings made either on EDGAR®
or on the System for Electronic Disclosure for Insiders (SEDI®). Data is provided “as is” and by using this site
you acknowledge that the information which comprises the data is filed by or on behalf of the SEDI filers or other
parties legally required or permitted to do so. Filings may at any time contain errors and by using this site you
acknowledge this fact. INK is not an investment advisory service, a financial planner, an investment advisor nor a
securities advisor. INK does not purport to tell people, or suggest to people, what they should buy or sell for
themselves. Opinions and recommendations contained herein should not be construed as investment advice. Do not
assume that any recommendations, insights, charts, theories, or philosophies will ensure profitable investment.
Users should always consult with and obtain advice from their professional licensed financial advisor, including
their tax advisor, to determine the suitability of any investment. INK recommends that anyone making an investment
or trading securities do so with caution. Users should perform full due diligence and investigate any security
fully before making an investment or before the execution of a security trade based upon information learned
through INK. Investors should obtain annual reports and other company information to complete their own due
diligence in any investment. Neither INK nor anyone affiliated with INK is responsible for any investment decision
made. INK employees may have an ownership or investment interest in any stock mentioned in this service or on this
website. On this site, there may be third party content, content from authors or links to third-party sites or
pages, the contents of which are not verified, maintained, controlled or supervised by INK. INK is not responsible
for and assumes no liability for the accuracy, completeness or timeliness of any third party content or authored
content provided herein or the information or contents of any linked sites or pages. The inclusion of any authored
content or link by us does not imply that INK recommends, approves or endorses the authored content or linked site
or pages. INK Edge® and INK Research® are registered trade-marks owned by INK Research Corp. SEDI®
is a registered trade-mark owned by the Alberta Securities Commission. Copyright © 2024 INK Research Corp. All rights reserved.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.
Please make the indicated changes including the new text: US quotes snapshot data provided by IEX. Additional price data and company information powered by Twelve Data.